ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

7 links0 made here, not in the record13 judgments2 judges (our rules as one)0 record changes seen
Model not recordedOur rules
Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT03675737Pembrolizumab (MK-3475)Plus Chemotherapy VersusPlacebo Plus Chemotherapyin Participants Gastric orGastroesophageal Junction(GEJ) Adenocarcinoma(MK-3475-859/KEYNOTE-859)Merck Sharp & Dohme LLCPhase 3 · completedRECORDThe record itselfVersions seen nightly since Sep 25, 2…›No new version seen since tracking began Sep 25, 2026.CONDITIONSStomach NeoplasmsThe registry's MeSH filing›Nov 14 · Our condition-kind rule · Finest filed termAs of now · Our main-condition rule (R9) · Main conditionMain conditionParkinson Disease 4, Autoso…The registry's MeSH filing›Nov 14 · Our condition-kind rule · MisfiledMisfiledDRUGSPembrolizumabIntervention entry›Nov 1 · A model not recorded · TestedNov 18 · Our role rule · TestedTestedCisplatinIntervention entry›Nov 1 · A model not recorded · BackgroundNov 18 · Our role rule · BackgroundBackgroundFluorouracilEntry “5-fluorouracil”, read by our n…›Nov 1 · A model not recorded · BackgroundNov 18 · Our role rule · BackgroundBackgroundOxaliplatinIntervention entry›Nov 1 · A model not recorded · BackgroundNov 18 · Our role rule · BackgroundBackgroundCapecitabineIntervention entry›Nov 1 · A model not recorded · BackgroundNov 18 · Our role rule · BackgroundBackground

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

Pembrolizumab

From the registry record2 judgments on this link
Role in the study, from the registry to what was judged
RegistryEntry “Pembrolizumab”the record gives no role
→judged=agrees
How the 2 judgments split100%of judgments with a known value say Tested
Tested · 2

All judgments on this study

WhenLinkJudgeDecisionState
Nov 1PembrolizumabA model not recordedTestedCurrent
Nov 1CisplatinA model not recordedBackgroundCurrent
Nov 1FluorouracilA model not recordedBackgroundCurrent
Nov 1OxaliplatinA model not recordedBackgroundCurrent
Nov 1CapecitabineA model not recordedBackgroundCurrent
Nov 14Stomach NeoplasmsOur condition-kind ruleFinest filed termCurrent
Nov 14Parkinson Disease 4, Autosomal Dominant Lewy BodyOur condition-kind ruleMisfiledCurrent
Nov 18PembrolizumabOur role ruleTestedAgrees
Nov 18CisplatinOur role ruleBackgroundAgrees
Nov 18FluorouracilOur role ruleBackgroundAgrees
Nov 18OxaliplatinOur role ruleBackgroundAgrees
Nov 18CapecitabineOur role ruleBackgroundAgrees
As of nowStomach NeoplasmsOur main-condition rule (R9)Main conditionCurrent